These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 384601)

  • 41. Investigation of the regioselectivity for the staudinger reaction and its application for the synthesis of aminoglycosides with N-1 modification.
    Li J; Chiang FI; Chen HN; Chang CW
    J Org Chem; 2007 May; 72(11):4055-66. PubMed ID: 17465564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel paromamine derivatives exploring shallow-groove recognition of ribosomal-decoding-site RNA.
    Simonsen KB; Ayida BK; Vourloumis D; Takahashi M; Winters GC; Barluenga S; Qamar S; Shandrick S; Zhao Q; Hermann T
    Chembiochem; 2002 Dec; 3(12):1223-8. PubMed ID: 12465030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes.
    Felmingham D; Jones K
    Drugs Exp Clin Res; 1989; 15(3):133-6. PubMed ID: 2752913
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Enzymes inactivating aminosides].
    Davies J
    Nouv Presse Med; 1979 Oct; 8(42):3393-7. PubMed ID: 231761
    [No Abstract]   [Full Text] [Related]  

  • 45. Structure-activity relationships of bivalent aminoglycosides and evaluation of their microbiological activities.
    Liang CH; Romero A; Rabuka D; Sgarbi PW; Marby KA; Duffield J; Yao S; Cheng ML; Ichikawa Y; Sears P; Hu C; Hwang SB; Shue YK; Sucheck SJ
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2123-8. PubMed ID: 15808482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A survey of clinical isolates of Enterobacteriaceae using a series of DNA probes for aminoglycoside resistance genes.
    Flamm RK; Phillips KL; Tenover FC; Plorde JJ
    Mol Cell Probes; 1993 Apr; 7(2):139-44. PubMed ID: 8391641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground.
    Shakil S; Khan R; Zarrilli R; Khan AU
    J Biomed Sci; 2008 Jan; 15(1):5-14. PubMed ID: 17657587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of protein dynamics and solvent in ligand recognition by promiscuous aminoglycoside-modifying enzymes.
    Serpersu EH; Norris AL
    Adv Carbohydr Chem Biochem; 2012; 67():221-48. PubMed ID: 22794185
    [No Abstract]   [Full Text] [Related]  

  • 49. Aminoglycoside antibiotics. Structures, functions, and resistance.
    Wright GD; Berghuis AM; Mobashery S
    Adv Exp Med Biol; 1998; 456():27-69. PubMed ID: 10549363
    [No Abstract]   [Full Text] [Related]  

  • 50. Chemical modification of aminoglycoside antibiotics. Some N-alkyl derivatives of sorbistin A1 (P-2563 P) and butirosin A.
    Nara K; Yoshioka K; Kida M
    Chem Pharm Bull (Tokyo); 1979 Jan; 27(1):65-75. PubMed ID: 85500
    [No Abstract]   [Full Text] [Related]  

  • 51. Enzymes that inactivate antibiotics in transit to their targets.
    Davies JE; Benveniste RE
    Ann N Y Acad Sci; 1974 May; 235(0):130-6. PubMed ID: 4527785
    [No Abstract]   [Full Text] [Related]  

  • 52. Substrate specificities and structure-activity relationships for the nucleotidylation of antibiotics catalyzed by aminoglycoside nucleotidyltransferase 2''-I.
    Gates CA; Northrop DB
    Biochemistry; 1988 May; 27(10):3820-5. PubMed ID: 2841975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
    Allen NE; Alborn WE; Kirst HA; Toth JE
    J Med Chem; 1987 Feb; 30(2):333-40. PubMed ID: 3543366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 4-N-Aminoacylation of substances derived from lysinomicin.
    Kurath P; Stanaszek RS; Cirovic M
    J Antibiot (Tokyo); 1982 Oct; 35(10):1338-44. PubMed ID: 7174518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aminoglycosides: activity and resistance.
    Mingeot-Leclercq MP; Glupczynski Y; Tulkens PM
    Antimicrob Agents Chemother; 1999 Apr; 43(4):727-37. PubMed ID: 10103173
    [No Abstract]   [Full Text] [Related]  

  • 56. Selective Protection of Secondary Amines as the N-Phenyltriazenes. Application to Aminoglycoside Antibiotics.
    Sonousi A; Crich D
    Org Lett; 2015 Aug; 17(16):4006-9. PubMed ID: 26294060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Antibiotics and protein binding].
    Tillement JP; Chauvelot L
    Therapie; 1978; 33(3):235-49. PubMed ID: 356336
    [No Abstract]   [Full Text] [Related]  

  • 58. 4-N-Aminoacylfortimicins E.
    Kurath P; Grampovnik D; Tadanier J; Martin JR; Egan RS; Stanaszek RS; Cirovic M; Washburn WH; Hill P; Dunnigan DA; Leonard JE; Johnson P; Goldstein AW
    J Antibiot (Tokyo); 1979 Sep; 32(9):884-90. PubMed ID: 511780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 2-deoxy-3-demethoxyfortimicin A.
    Tadanier J; Hallas R
    J Antibiot (Tokyo); 1982 Jun; 35(6):688-91. PubMed ID: 7118725
    [No Abstract]   [Full Text] [Related]  

  • 60. Synthesis of 3'-deoxyseldomycin 5.
    Matsushima H; Mori Y; Kitaura K
    J Antibiot (Tokyo); 1977 Oct; 30(10):890-2. PubMed ID: 591450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.